Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI
Deepak L. Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI Advisory Board
Benjamin Scirica MD
Benjamin Morgan Scirica MD Associate Editor
Douglas Zipes MD
Douglas P. Zipes MD Editor-in-Chief
See All Experts
featured
Published in Cardiology

Journal Scan / Research · September 15, 2015

Better Outcomes With Addition of Ezetimibe to Simvastatin

Circulation

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Peter Libby MD

Circulation
Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT
Circulation 2015 Sep 01;[EPub Ahead of Print], EA Bohula, RP Giugliano, CP Cannon, J Zhou, SA Murphy, JA White, AM Tershakovec, MA Blazing, E Braunwald

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated